No phaseStatus unknown

Interleukin-1 Inhibitor for Refractory CTD-ILD: A Clinical Observational Study and Mechanistic Investigation

Sponsor

Nanjing Drum Tower Hospital

Enrolment

20 planned

Conditions

Connective tissue disease-associated interstitial lung disease

Interventions

Interleukin-1 Inhibitor therapy

Ages

adults, older adults

Registry

ChiCTR2600132409

Full record on the Chinese Clinical Trial RegistrySource: WHO ICTRP, processed 21 September 2026